Back to search

Article

Understanding barriers to the introduction of precision medicine in non-small cell lung cancer: a qualitative interview study

2021-02-05

Abstract excerpt

<h4>Background: </h4> While treatments targeting genetic mutations and alterations in non-small cell lung cancer (NSCLC) have been available since 2010, the adoption of such examples of precision medicine into clinical practice has historically been slow. This means that patients with NSCLC may not have received life improving and extending treatments which should have been available to them. The purpose of this q...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b894e5e3-c259-55e1-b404-7bfa0ecb8149
DOI
10.12688/wellcomeopenres.16528.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Understanding barriers to the introduction of precision medicine in non-small cell lung cancer: a qualitative interview studyDOI 10.12688/wellcomeopenres.16528.1
Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocolSemantic proximity
Barries in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World-Evidence ScenarioSemantic proximity
Molecular Pathology Testing for Non-small Cell Lung Cancer: An Observational Study of Elements Currently Present in Request Forms and Result Reports and The Opinion of Different StakeholdersSemantic proximity
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.Semantic proximity
Physician preferences of biomarker testing strategies in newly diagnosed stage IV non-small cell lung cancer patients.Semantic proximity
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?Semantic proximity
Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.Semantic proximity
Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?Semantic proximity
Awareness, Knowledge, Perceived Benefits, and Barriers Regarding Precision Medicine and Willingness to Participate in a National Registry: Comparison of Cancer Patients and the General PopulationSemantic proximity
Investigating Needs to Develop Training in Precision Medicine for Frontline Healthcare Professionals: A Focus Group StudySemantic proximity
Does Safety Netting for Lung Cancer Symptoms Help Patients to Reconsult Appropriately? A Qualitative StudySemantic proximity
Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK.Semantic proximity
Select a neighboring publication to make it the new centre.